As of 2026-08-24, aTyr Pharma, Inc. Common Stock (ATYR) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.6%, relative volume 1.06×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ATYR is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $265K notional. Top 3 carry $316K.
Held by 19 ETFs · $6M across latest filings · largest weight 0.01% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $2K |
| — |
| URTY | 0.00% | $2K | — |
| UWM | 0.00% | $2K | — |
| HDG | 0.00% | $49 | — |
| RB | 0.00% | $15 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ATYR Jan avg: 9.68% median: 9.68% win: 100% σ: 4.31% n: 2 2024-06-06 → 2026-07-31 | ATYR Feb avg: 5.59% median: 5.59% win: 100% σ: 4.43% n: 2 2024-06-06 → 2026-07-31 | ATYR Mar avg: -21.19% median: -21.19% win: 0% σ: 3.47% n: 2 2024-06-06 → 2026-07-31 | ATYR Apr avg: 9.21% median: 9.21% win: 100% σ: 8.05% n: 2 2024-06-06 → 2026-07-31 | ATYR May avg: -1.99% median: -1.99% win: 50% σ: 43.58% n: 2 2024-06-06 → 2026-07-31 | ATYR Jun avg: 3.05% median: 10.01% win: 67% σ: 15.11% n: 3 2024-06-06 → 2026-07-31 | ATYR Jul avg: 0.47% median: -6.90% win: 33% σ: 23.65% n: 3 2024-06-06 → 2026-07-31 | ATYR Aug avg: 4.21% median: 4.21% win: 50% σ: 13.82% n: 2 2024-06-06 → 2026-07-31 (current) | ATYR Sep avg: -46.24% median: -46.24% win: 0% σ: 57.07% n: 2 2024-06-06 → 2026-07-31 | ATYR Oct avg: 48.66% median: 48.66% win: 100% σ: 40.47% n: 2 2024-06-06 → 2026-07-31 | ATYR Nov avg: 1.63% median: 1.63% win: 50% σ: 16.27% n: 2 2024-06-06 → 2026-07-31 | ATYR Dec avg: 1.44% median: 1.44% win: 100% σ: 1.57% n: 2 2024-06-06 → 2026-07-31 |